Quantcast

Latest Organofluorides Stories

2014-01-14 08:29:36

SAN FRANCISCO, Jan. 14, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) announced today that the Independent Data Monitoring Committee (DMC) created to provide safety oversight for the Company's pivotal clinical study for etirinotecan pegol (NKTR-102) has recommended continuation of the BEACON phase 3 trial, based upon the completion of a planned interim efficacy analysis in accordance with the DMC charter. The BEACON trial is evaluating NKTR-102 versus an agent of physician's...

2014-01-13 08:30:09

FLORHAM PARK, N.J., Jan. 13, 2014 /PRNewswire/ -- Shionogi Inc. today announced that it has entered into an exclusive, multi-year agreement with Noven Pharmaceuticals to co-promote Brisdelle(TM) (paroxetine) capsules, 7.5 mg, the first and only non-hormonal prescription drug approved for the treatment of moderate to severe hot flashes associated with menopause. Under the terms of the agreement, Shionogi will promote Brisdelle, along with Osphena(TM) (ospemifene), its non-estrogen oral...

2014-01-13 08:29:50

Co-Promotion to Extend Physician Awareness of the First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Menopausal Hot Flashes MIAMI and NEW YORK, Jan. 13, 2014 /PRNewswire/ -- Noven Pharmaceuticals, Inc. today announced that it has entered into an agreement with Shionogi Inc. to co-promote Brisdelle(TM) (paroxetine) capsules, 7.5 mg. The agreement will help extend physician awareness of the first and only FDA-approved, non-hormonal treatment for moderate to severe...

2014-01-10 12:22:26

WASHINGTON, Jan. 10, 2014 /PRNewswire-USNewswire/ -- Environmental Investigation Agency (EIA): In a major win for the climate, the Verified Carbon Standard (VCS), the world's leading voluntary greenhouse gas program, has announced that it will no longer approve or accept for consideration new methodologies and projects relating to HFC-23, acknowledging progress under the Montreal Protocol, G-20 and other bilateral government discussions on the international regulation of hydrofluorocarbons...

2014-01-09 23:25:48

The DrugRisk Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Philadelphia, PA (PRWEB) January 09, 2014 The drug safety resource DrugRisk.com has added new information to the site for patients and families of those who have taken the antipsychotic drug Risperdal. According to court documents, plaintiffs alleging the drug caused abnormal breast growth have asked a judge to unseal data from...

2014-01-09 08:28:38

LONDON, Jan. 9, 2014 /PRNewswire/ -- The Avillion Group (Avillion), a co-developer of late-stage clinical assets, announced today that it has entered into an exclusive collaborative development agreement with Pfizer Inc. to conduct a global Phase 3 clinical trial of Pfizer's BOSULIF(®) (bosutinib). The trial, which will be conducted across multiple sites in the United States, Asia and Europe, will evaluate BOSULIF, administered at a starting dose level of 400 mg daily, as a...

2014-01-09 00:21:30

- First approved combination of oral targeted therapies for unresectable or metastatic melanoma with BRAF V600E or V600K mutations[1] LONDON, Jan. 8, 2014 /PRNewswire/ -- GlaxoSmithKline plc [LSE/NYSE: GSK ] announced today that the U.S. Food and Drug Administration (FDA) has approved Mekinist(® )(trametinib) for use in combination with Tafinlar(®) (dabrafenib) for the treatment of patients with unresectable melanoma (melanoma that cannot be removed by surgery) or metastatic melanoma...

2014-01-08 12:23:56

LONDON, Jan. 8, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Fluoropolymer Market, By Type (PTFE, PVDF, FEP, Fluoroelastomers) & Application (Automotive, Electrical & Electronics, Chemical Processing, Industrial) - Global Trends & Forecast to 2018 Fluoropolymers are specialized polymeric materials witnessing strong market growth. This growth is driven by the end-user markets where fluoropolymers are extensively used owing to their...

2014-01-07 23:00:57

The Firm is investigating Risperdal lawsuits on behalf of individuals treated with the antipsychotic medication and who allegedly developed gynecomastia, or male breast growth, due to their use of the drug. New York, New York (PRWEB) January 07, 2014 As Risperdal lawsuits, (http://www.risperdallawsuitcenter.com/) including many that allege a connection between the use of Risperdal and gynecomastia (male breast growth), continue to move forward in courts around the U.S., a new study has...

2014-01-04 23:00:58

The Firm is evaluating Risperdal lawsuits on behalf of alleged victims of Risperdal and gynecomastia, or male breast growth. New York, New York (PRWEB) January 04, 2014 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/ ) involving allegations that the atypical antipsychotic medication caused patients to develop gynecomastia (male breast growth) and other serious side effects continue to move forward in courts around the country, Bernstein Liebhard LLP notes that findings from...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related